Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Lung Cancer

  Free Subscription


Articles published in Cancer Cell

Retrieve available abstracts of 24 articles:
HTML format
Text format



Single Articles


    May 2018
  1. FRUH M, Peters S
    Genomic Features of Response to Combination Immunotherapy in Lung Cancer.
    Cancer Cell. 2018;33:791-793.
    PubMed     Text format     Abstract available


    April 2018
  2. HELLMANN MD, Callahan MK, Awad MM, Calvo E, et al
    Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer.
    Cancer Cell. 2018 Apr 21. pii: S1535-6108(18)30172.
    PubMed     Text format     Abstract available


  3. HELLMANN MD, Nathanson T, Rizvi H, Creelan BC, et al
    Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer.
    Cancer Cell. 2018 Apr 12. pii: S1535-6108(18)30123.
    PubMed     Text format     Abstract available


    December 2017
  4. BERGER AH, Brooks AN, Wu X, Shrestha Y, et al
    High-throughput Phenotyping of Lung Cancer Somatic Mutations.
    Cancer Cell. 2017;32:884.
    PubMed     Text format    


    September 2017
  5. VAZ M, Hwang SY, Kagiampakis I, Phallen J, et al
    Chronic Cigarette Smoke-Induced Epigenomic Changes Precede Sensitization of Bronchial Epithelial Cells to Single-Step Transformation by KRAS Mutations.
    Cancer Cell. 2017;32:360-376.
    PubMed     Text format     Abstract available


  6. CLARK SJ, Molloy PL
    Smoke-Induced Changes to the Epigenome Provide Fertile Ground for Oncogenic Mutation.
    Cancer Cell. 2017;32:278-280.
    PubMed     Text format     Abstract available


    August 2017
  7. BEST MG, Sol N, In 't Veld SGJG, Vancura A, et al
    Swarm Intelligence-Enhanced Detection of Non-Small-Cell Lung Cancer Using Tumor-Educated Platelets.
    Cancer Cell. 2017;32:238-252.
    PubMed     Text format     Abstract available


    April 2017
  8. SCHOENFELD JD, Sibenaller ZA, Mapuskar KA, Wagner BA, et al
    O2- and H2O2-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological Ascorbate.
    Cancer Cell. 2017;31:487-500.
    PubMed     Text format     Abstract available


    March 2017
  9. WIELAND E, Rodriguez-Vita J, Liebler SS, Mogler C, et al
    Endothelial Notch1 Activity Facilitates Metastasis.
    Cancer Cell. 2017;31:355-367.
    PubMed     Text format     Abstract available


    February 2017
  10. GARDNER EE, Lok BH, Schneeberger VE, Desmeules P, et al
    Chemosensitive Relapse in Small Cell Lung Cancer Proceeds through an EZH2-SLFN11 Axis.
    Cancer Cell. 2017;31:286-299.
    PubMed     Text format     Abstract available


  11. JUSTILIEN V, Ali SA, Jamieson L, Yin N, et al
    Ect2-Dependent rRNA Synthesis Is Required for KRAS-TRP53-Driven Lung Adenocarcinoma.
    Cancer Cell. 2017;31:256-269.
    PubMed     Text format     Abstract available


  12. BERNS K, Berns A
    Awakening of "Schlafen11" to Tackle Chemotherapy Resistance in SCLC.
    Cancer Cell. 2017;31:169-171.
    PubMed     Text format     Abstract available


    December 2016
  13. MOLLAOGLU G, Guthrie MR, Bohm S, Bragelmann J, et al
    MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition.
    Cancer Cell. 2016 Dec 31. pii: S1535-6108(16)30600.
    PubMed     Text format     Abstract available


    July 2016
  14. BERGER AH, Brooks AN, Wu X, Shrestha Y, et al
    High-throughput Phenotyping of Lung Cancer Somatic Mutations.
    Cancer Cell. 2016 Jul 28. pii: S1535-6108(16)30282.
    PubMed     Text format     Abstract available


  15. SAHA S, Biswas SK
    Tumor-Associated Neutrophils Show Phenotypic and Functional Divergence in Human Lung Cancer.
    Cancer Cell. 2016;30:11-3.
    PubMed     Text format     Abstract available


    June 2016
  16. SINGHAL S, Bhojnagarwala PS, O'Brien S, Moon EK, et al
    Origin and Role of a Subset of Tumor-Associated Neutrophils with Antigen-Presenting Cell Features in Early-Stage Human Lung Cancer.
    Cancer Cell. 2016 Jun 30. pii: S1535-6108(16)30226.
    PubMed     Text format     Abstract available


    May 2016
  17. BRADY JJ, Chuang CH, Greenside PG, Rogers ZN, et al
    An Arntl2-Driven Secretome Enables Lung Adenocarcinoma Metastatic Self-Sufficiency.
    Cancer Cell. 2016;29:697-710.
    PubMed     Text format     Abstract available


    April 2016
  18. FORTIN J, Mak TW
    Targeting PI3K Signaling in Cancer: A Cautionary Tale of Two AKTs.
    Cancer Cell. 2016;29:429-31.
    PubMed     Text format     Abstract available


  19. FREED DM, Park JH, Radhakrishnan R, Lemmon MA, et al
    Deletion Mutations Keep Kinase Inhibitors in the Loop.
    Cancer Cell. 2016;29:423-5.
    PubMed     Text format     Abstract available


  20. HALAMA N, Zoernig I, Berthel A, Kahlert C, et al
    Tumoral Immune Cell Exploitation in Colorectal Cancer Metastases Can Be Targeted Effectively by Anti-CCR5 Therapy in Cancer Patients.
    Cancer Cell. 2016;29:587-601.
    PubMed     Text format     Abstract available


  21. WANG Q, Yu WN, Chen X, Peng XD, et al
    Spontaneous Hepatocellular Carcinoma after the Combined Deletion of Akt Isoforms.
    Cancer Cell. 2016;29:523-35.
    PubMed     Text format     Abstract available


    March 2016
  22. ALI SA, Justilien V, Jamieson L, Murray NR, et al
    Protein Kinase Ciota Drives a NOTCH3-dependent Stem-like Phenotype in Mutant KRAS Lung Adenocarcinoma.
    Cancer Cell. 2016;29:367-78.
    PubMed     Text format     Abstract available


    January 2016
  23. SERRESI M, Gargiulo G, Proost N, Siteur B, et al
    Polycomb Repressive Complex 2 Is a Barrier to KRAS-Driven Inflammation and Epithelial-Mesenchymal Transition in Non-Small-Cell Lung Cancer.
    Cancer Cell. 2016;29:17-31.
    PubMed     Text format     Abstract available


    September 2015
  24. WANG X, Zhao X, Feng C, Weinstein A, et al
    IL-36gamma Transforms the Tumor Microenvironment and Promotes Type 1 Lymphocyte-Mediated Antitumor Immune Responses.
    Cancer Cell. 2015;28:296-306.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: